| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/31/2003 | US20030143672 Providing conservative or semi-conservative amino acid substitutions at positions 3 and/or 5 and/or 7 of these epitopes, useful in eliciting immune responses with respect to corresponding wildtype epitopes |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/31/2003 | US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents |
| 07/31/2003 | US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation |
| 07/31/2003 | US20030143633 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening of these factors and the inhibitors |
| 07/31/2003 | US20030143626 Such as cyclin-dependent kinases and/or bax genes/proteins covalently linked to platform compound (thioredoxin); drug screening |
| 07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/31/2003 | US20030143622 Human RNA binding proteins |
| 07/31/2003 | US20030143621 Contacting a cellular component with a reagent which binds to PC-1 (prostate cancer-1) protein |
| 07/31/2003 | US20030143620 Carbohydrate ligands specific for MHC molecules |
| 07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
| 07/31/2003 | US20030143595 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143583 Novel response element |
| 07/31/2003 | US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 07/31/2003 | US20030143526 Recombinanr hhv8 dna |
| 07/31/2003 | US20030143281 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143245 Multivalent streptococcal vaccine compositions and methods for use |
| 07/31/2003 | US20030143244 For preparation of D-amino acids starting from 5'-substituted hydantoins |
| 07/31/2003 | US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin |
| 07/31/2003 | US20030143212 Corneal cells expressing active agents and methods of use thereof |
| 07/31/2003 | US20030143211 Providing a platelet-containing fluid sample at a first temperature; adding to the sample, an amount of an exothermic salt sufficient to activate the platelets |
| 07/31/2003 | US20030143210 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 07/31/2003 | US20030143208 For therapy of neurodegenerative disorders associated with oxidative damage and subsequent neuronal cell loss, including, but not limited to, Parkinson's disease and head trauma |
| 07/31/2003 | US20030143192 Chemokine beta-7 |
| 07/31/2003 | US20030143190 For modulating the immune system; therapy of cancer |
| 07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | CA2511257A1 Stimulation of bone growth and cartilage formation with thrombin peptide derivatives |
| 07/31/2003 | CA2511229A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities |
| 07/31/2003 | CA2510751A1 Multimers of receptor-binding ligands |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2474766A1 Stem cell maturation for all tissue types |
| 07/31/2003 | CA2474763A1 Fiber shaft modifications for efficient targeting |
| 07/31/2003 | CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | CA2474344A1 Expansion of renewable stem cell populations |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2473944A1 Methods and compositions for rna interference |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | CA2473555A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/31/2003 | CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2472725A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2472723A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2472067A1 Methods and apparatus for generating and utilizing linear moving optical gradients |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/30/2003 | EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 07/30/2003 | EP1331266A1 Cells producing antibody compositions |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1331264A1 Method of culturing human chondrocytes |
| 07/30/2003 | EP1331228A1 Method of screening antiplatelet |
| 07/30/2003 | EP1331219A1 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them |
| 07/30/2003 | EP1330647A2 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 07/30/2003 | EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 07/30/2003 | EP1330538A2 Cd36 as a heat shock protein receptor and uses thereof |
| 07/30/2003 | EP1330535A2 Kini-3 motor protein and methods for its use |
| 07/30/2003 | EP1330531A2 Influenza virus vector for infection of dendritic cells |
| 07/30/2003 | EP1330530A2 Herbicide-tolerant plants through bypassing metabolic pathway |
| 07/30/2003 | EP1330528A2 Regulation of human serine-threonine protein kinase |
| 07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330517A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 07/30/2003 | EP1330514A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 07/30/2003 | EP1330475A2 Neuromedin u delta polypeptides |
| 07/30/2003 | EP1330469A2 Glycoproteins and methods of use therefof |
| 07/30/2003 | EP1330306A2 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 07/30/2003 | EP1330269A1 Method of inactivating micro-organisms |
| 07/30/2003 | EP1330264A2 Vaccine for treating allergy |
| 07/30/2003 | EP1330263A2 Method for down-regulating ige |
| 07/30/2003 | EP1330176A2 METHOD FOR i IN VIVO /i , i EX VIVO /i AND i IN VITRO /i REPAIR AND REGENERATION OF CARTILAGE AND COLLAGEN AND BONE REMODELING |
| 07/30/2003 | EP1178832B1 Novel medicament compositions, based on tiotropium bromide and salmeterol |
| 07/30/2003 | EP1158849A4 Plant ligand-gated ion channels |
| 07/30/2003 | EP0983074B1 Non-myeloablative tolerogenic treatment |
| 07/30/2003 | EP0971580B1 Regulatory element for expressing genes in plants |
| 07/30/2003 | EP0943097B1 METHOD TO DETECT IgE |
| 07/30/2003 | CN1433476A Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 07/30/2003 | CN1433473A Modification of polysaccharide containing materials |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1433267A High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
| 07/30/2003 | CN1432645A Human cell bank and its application in autogenous cell transplantation and tissue repair |
| 07/29/2003 | US6600094 Recombinant plant expression vector comprising isolated cDNA nucleotide sequence encoding farnesyl pyrophosphate synthase (FPS) derived from seedlings of sunflower (Helianthus annus) |
| 07/29/2003 | US6600090 Genetically engineered plant for use in the generation and propagation of disease and pest resistant plant |
| 07/29/2003 | US6600087 Propagation of cattle embryo; obtain fetal tissue, extract nucleus, transfer nucleus to oocyte, activate cytoplasm complex, propagate cells, implant cells into cattle, allow fetus to propagate |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600029 Expression cassette for use as tools in the transfer of preferential nucleotide sequences into cells |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6600012 Lipid-modified muc-1 derivatives |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599744 Expression vector for use as tool in the transfer nucleotide sequences and generation of heterologous proteins in cells |
| 07/29/2003 | US6599743 Culturing on different media |
| 07/29/2003 | US6599740 Method of using fish plasma components for tissue culture |
| 07/29/2003 | US6599739 Papillomavirus viral vector for use in the transfer of nucleotide sequences |
| 07/29/2003 | US6599738 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 07/29/2003 | US6599734 Culturing cells or tissues; obtain cells, incubate with nutrient broth, propagte cells |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |